# FDA Inspection 1106275 - Vitalant - September 05, 2019

Source: https://www.keypedia.com/records/fda_inspections/vitalant/9d546df9-db1d-4bb5-9a5b-86d5c3d10db7
Source feed: FDA_Inspections

> FDA Inspection 1106275 for Vitalant on September 05, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1106275
- Company Name: Vitalant
- Inspection Date: 2019-09-05
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1258010 - 2024-11-22](https://www.keypedia.com/records/fda_inspections/vitalant/17d9e9ab-e4de-4376-a714-29ef611b9d5f)
- [FDA Inspection 1258010 - 2024-11-22](https://www.keypedia.com/records/fda_inspections/vitalant/ef531390-28ec-4538-840b-31ea72884326)
- [FDA Inspection 1000905 - 2017-02-10](https://www.keypedia.com/records/fda_inspections/vitalant/16457b79-8da2-405e-8b06-7a324482a026)
- [FDA Inspection 937619 - 2015-07-29](https://www.keypedia.com/records/fda_inspections/vitalant/5de5c76b-294b-41fa-a732-25805f988bd8)
- [FDA Inspection 848182 - 2013-09-13](https://www.keypedia.com/records/fda_inspections/vitalant/5be7f3d8-d2f0-469e-bae3-e9abd3f4563d)

Company: https://www.keypedia.com/companies/vitalant/7a5079bf-12d6-460a-b20d-eacf8b0f3f11

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d